Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Qurate Retail Inc Series A (QVCAQ) vs BIO-TECHNE Corp (TECH) Price & Performance

Qurate Retail Inc Series ATrade
BIO-TECHNE CorpTrade

Price performance (Past 24H)

Key statistics

Qurate Retail Inc Series A vs BIO-TECHNE Corp — how do they compare? Qurate Retail Inc Series A trades at $0.04 (market cap $653.75K), while BIO-TECHNE Corp trades at $71.73 (market cap $11.16B). The key difference: BIO-TECHNE Corp is far larger — about 17070.7× Qurate Retail Inc Series A's market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Qurate Retail Inc Series A pays none. Which is the better fit depends on your goals.

QVCAQTECH
Market Cap
$653.75K$11.16B
Sector
Consumer CyclicalHealth
52-Week High
$15.03$72.12
52-Week Low
$0.05$43.31
Enterprise Value
$4.73B$11.24B
Dividend Yield
0.45%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Qurate Retail Inc Series A

No Aura AI signal available yet.

BIO-TECHNE Corp

Bio-Techne (TECH) trades at $71.63, down 0.68% on the day, near its all-time high following a $73 per share acquisition offer from Merck KGaA. The stock shows bullish technical signals with strong moving averages and ADX trends. Fundamentally, the company reported mixed quarterly earnings but maintains solid gross margins of 64.96%. Recent news is dominated by the proposed $11.3 billion buyout, driving significant investor interest and legal scrutiny over the transaction's fairness.

The outlook is heavily influenced by the pending acquisition, with upside capped near the $73 offer price. Risks include shareholder litigation and regulatory approval delays. Analyst consensus is split evenly between Buy and Hold, reflecting uncertainty around deal completion. The stock presents a potential arbitrage opportunity if the acquisition proceeds, but carries event risk if the transaction fails.

Returns comparison

Trailing returns across standard periods

About Qurate Retail Inc Series A

Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, primarily using their televised shopping programs and via the Internet through their websites and mobile applications

Read more on QVCAQ

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Read more on TECH